“You are able to’t have that safer provide without there being a source,” he said, adding they’re largely wanting to sell to researchers and entrance-line employees in place of directly to drug buyers.File?r m?r? th?n 30 ???r? C?l?mb?? h?? shown ?t? ??mm?tm?nt – paying out a v?r? h?gh ???t in hum?n l?v?? – w?th ?v?r??m?ng the drug dilem